Literature DB >> 3353731

Pharmacokinetic studies of standard unfractionated heparin, and low molecular weight heparins in the rabbit.

B Boneu1, C Caranobe, Y Cadroy, F Dol, A M Gabaig, D Dupouy, P Sie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3353731     DOI： 10.1055/s-2007-1002751

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  15 in total

Review 1.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Chronic kidney disease in acute coronary syndromes.

Authors:  Giancarlo Marenzi; Angelo Cabiati; Emilio Assanelli
Journal:  World J Nephrol       Date:  2012-10-06

3.  Heparin in interventional radiology: a therapy in evolution.

Authors:  Stuart B Resnick; Stephanie H Resnick; Joshua L Weintraub; Nishita Kothary
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

4.  Sulodexide promotes arterial relaxation via endothelium-dependent nitric oxide-mediated pathway.

Authors:  Joseph D Raffetto; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-04-20       Impact factor: 5.858

Review 5.  Antithrombotic therapy for patients with STEMI undergoing primary PCI.

Authors:  Francesco Franchi; Fabiana Rollini; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

6.  Stabilized infective endocarditis and altered heparin responsiveness during cardiopulmonary bypass.

Authors:  Sungwon Na; Jae Kwang Shim; Duk-Hee Chun; Dae Hee Kim; Seong Wook Hong; Young-Lan Kwak
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

7.  Clinical use of the low-molecular-weight heparins in cancer patients: focus on the improved patient outcomes.

Authors:  Bo H Chao; Lisa Lepeak; Ticiana Leal; H Ian Robins
Journal:  Thrombosis       Date:  2011-04-12

8.  Use of sulodexide in patients with peripheral vascular disease.

Authors:  J Lasierra-Cirujeda; P Coronel; Mj Aza; M Gimeno
Journal:  J Blood Med       Date:  2010-06-15

9.  Sulodexide Improves Contraction and Decreases Matrix Metalloproteinase-2 and -9 in Veins Under Prolonged Stretch.

Authors:  Joseph D Raffetto; Wentao Yu; Xi Wang; Fiorella Calanni; Paolo Mattana; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2020-03       Impact factor: 3.271

10.  Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery.

Authors:  Zaishen Jia; Ganzhong Tian; Yupeng Ren; Zhiquan Sun; Wei Lu; Xiaotong Hou
Journal:  J Transl Med       Date:  2015-02-01       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.